NCT06141993View on ClinicalTrials.gov

ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

May 13, 2024

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions
Prostate CancerProstate AdenocarcinomaProstate Cancer MetastaticCastration-resistant Prostate Cancer
Trial Locations (3)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

27710

RECRUITING

Duke University Medical Center, Durham

53792

RECRUITING

University of Wisconsin-Madison, Madison

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

University of Wisconsin, Madison

OTHER

collaborator

Memorial Sloan Kettering Cancer Center

OTHER

lead

Duke University

OTHER

NCT06141993 - ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials | Biotech Hunter | Biotech Hunter